Cargando…
A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM‐STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC) is characterized by its dense fibrotic microenvironment and highly malignant nature, which are associated with chemotherapy resistance and very poor prognosis. Although circRNAs have emerged as important regulators in cancer biology, their role in ICC remains la...
Autores principales: | Chen, Zhi‐Wen, Kang, Feng‐Ping, Xie, Cheng‐Ke, Liao, Cheng‐Yu, Li, Ge, Wu, Yong‐Ding, Lin, Hong‐Yi, Zhu, Shun‐Cang, Hu, Jian‐Fei, Lin, Cai‐Feng, Huang, Yi, Tian, Yi‐Feng, Huang, Long, Wang, Zu‐Wei, Chen, Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646249/ https://www.ncbi.nlm.nih.gov/pubmed/37789644 http://dx.doi.org/10.1002/advs.202303814 |
Ejemplares similares
-
Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma
por: Fu, Kui, et al.
Publicado: (2020) -
Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect
por: Bin, Yu-Ling, et al.
Publicado: (2022) -
Invisible Trojan-horse attack
por: Sajeed, Shihan, et al.
Publicado: (2017) -
HIV and Mature Dendritic Cells: Trojan Exosomes Riding the Trojan Horse?
por: Izquierdo-Useros, Nuria, et al.
Publicado: (2010) -
Trojan‐Horse‐Like Stimuli‐Responsive Microcapsules
por: Mou, Chuan‐Lin, et al.
Publicado: (2018)